Technology

Aidoc Pioneers Next-Generation AI with CARE1™ Foundation Model, Revolutionizing CT Imaging Standards

Published

1 year ago

December 2, 2024

First application based on CARE1™ has been submitted for FDA review

NEW YORK, Dec. 2, 2024 /PRNewswire/ — Aidoc, the global leader in clinical AI, has developed CARE1™ (Clinical AI Reasoning Engine, Version 1), a groundbreaking clinical-grade foundation model for CT imaging, the first step in a multi-year investment in Aidoc’s Clinical AI Reasoning Engine (CARE™) framework. Trained on millions of exams and leveraging advanced multimodal capabilities, the CARE™ framework was developed to establish a new benchmark for precision and speed in developing clinical AI solutions. This innovation is designed to empower clinicians with unparalleled diagnostic accuracy and efficiency, unlocking AI’s full potential to tackle critical healthcare challenges by minimizing diagnostic delays, optimizing workflows and improving patient outcomes. CARE1™ is the culmination of relentless innovation, a bold vision and a significant investment of resources dedicated to this mission.

“Eighteen months ago, we embarked on an ambitious journey to redefine how clinical AI is developed and, in turn, how it serves healthcare,” said Michael Braginsky, CTO of Aidoc. “By unlocking new possibilities for AI, we aim to support clinicians in tackling complex challenges and help them set a new standard for patient care that the prior AI technologies couldn’t achieve. The CARE™ framework will gradually serve as the backbone of Aidoc’s AI solutions, enabling the development of versatile, high-performance AI capable of detecting a broad spectrum of critical conditions in real-time.”

Potential For Unmatched Accuracy Through Expertise, Scale and Innovation

What sets the CARE™ framework apart from other foundation models is its potential for unprecedented accuracy, with internal validations showing it may surpass the performance of Aidoc’s existing AI algorithms, which have already delivered proven clinical outcomes at scale. This breakthrough stems from a combination of unique factors:

Deep Clinical AI Expertise: With nearly a decade of experience in clinical AI and the largest install base in the industry, Aidoc has unparalleled experience in navigating the complexities of medical imaging. From managing missing or inconsistent data to addressing variability across diverse clinical settings, Aidoc has honed the ability to turn these challenges into opportunities, creating models that are not only accurate but also exceptionally robust.Purpose-Built Infrastructure: Aidoc’s advanced AI infrastructure has been meticulously developed to meet the demanding requirements of clinical-grade AI. Central to this is a robust validation framework, refined over years of building and deploying proven solutions in clinical settings. This framework ensures that every aspect of CARE1’s™ performance is rigorously tested and measured with precision. Aidoc focuses on rigorous internal validation for CARE1™ using a large, diverse dataset that reflects real-world clinical settings, ensuring reliable results. Significant Financial Investment: Delivering a foundation model of CARE1’s™ caliber required substantial investment. Aidoc’s strong financial backing enabled comprehensive data processing, extensive training, and rigorous testing, ensuring the delivery of this groundbreaking innovation at the highest level of quality and reliability.Unrivaled Data Scale: CARE1™ achieved groundbreaking results by training on a scale of data previously unattainable, spanning millions of cases across various conditions and anatomies. For the first time, this allowed a model to truly grasp the entire domain rather than focus on specific medical conditions, potentially unlocking unprecedented diagnostic power. Remarkably, this achievement leveraged only a fraction of Aidoc’s comprehensive dataset, underscoring the immense potential for further advancements.

By combining expertise, scale and innovation, CARE1™ is designed to redefine what’s possible in clinical AI and is well positioned to set a new benchmark for accuracy, versatility and reliability in healthcare diagnostics.

FDA Submission: A First Step Toward Transformative AI

As part of Aidoc’s commitment to robust and regulated AI, the company has already submitted its first real-world derivative of the CARE1™ Foundation Model for FDA 510(k) review. This initial application leveraged CARE1™ in Aidoc’s retrained rib fractures triage module with the addition of a pre-training layer. This submission reflects Aidoc’s approach to safely and rigorously transitioning to foundation model-based AI solutions in real-world clinical settings.

“We decided to start this shift by transforming the rib fractures triage module to be CARE1™-enabled, allowing us to begin learning how to measure, validate and ultimately bring foundation model-enabled algorithms to production in clinical settings,” added Braginsky. “This marks a pivotal shift in AI development at Aidoc. We’ve fully committed to foundation model technology because it’s clear this approach surpasses anything we’ve seen before. At the same time, we are steadfast in ensuring this transition is done with precision, focusing on safety, rigorous validation and a comprehensive understanding of this groundbreaking model’s behavior to ensure it delivers meaningful clinical impact.”

Shaping the Future of AI-Driven Healthcare

This breakthrough marks a transformative moment for Aidoc and the future of AI in medicine:

For AI Development: CARE™ framework will accelerate the creation of highly accurate models and enable entirely new applications, driving faster deployment to meet evolving healthcare needs.For AI Integration: As CARE™ framework and other foundation models enhance the ability to develop clinically meaningful AI modules, the challenge of their seamless integration into healthcare systems is increasing exponentially. This is especially true as the number of AI modules grows, making it harder to ensure they remain user friendly and harmonized. Aidoc’s aiOS™ platform provides health systems with the robust infrastructure needed to incorporate both Aidoc-developed and third-party AI models into sophisticated clinical workflows while maintaining usability and efficiency.

“The future of clinical AI is being reshaped by foundation models, which are set to revolutionize diagnostic workflows in healthcare. We’re encouraged to see the development of these transformative technologies by various leading players, as it underscores their immense potential,” said Elad Walach, CEO of Aidoc. “Ultimately, the true test of success lies in achieving the required accuracy for production-grade solutions. As we’ve all learned over the past decade of advancing clinical AI, the greatest challenge is delivering meaningful outcomes in real-world clinical settings. With CARE1™, Aidoc is just beginning to explore the immense possibilities that foundation models can unlock. Our mission has always been to empower providers to transform the core of diagnostic work, and CARE1™ is only the tip of the iceberg in an exciting journey toward delivering even greater value across the healthcare ecosystem.”

About Aidoc

Aidoc is a pioneering force in clinical AI. We focus on aiding and empowering healthcare teams to optimize patient treatment, which results in improved economic value and clinical outcomes. Built on Aidoc’s proprietary aiOS™, we analyze and aggregate medical data to enable care teams to operationalize the unexpected and work seamlessly with a continued focus on the patient. Used in more than 1,000 medical centers worldwide, Aidoc has the most FDA clearances (17) in clinical AI and its AI-based solutions cover 75 percent of patient populations, enabling physicians to make informed decisions based on real-time data. Visit Aidoc.com to see how we are connecting all points of care with always on AI.

Photo: https://mma.prnewswire.com/media/2570424/Aidoc.jpg
Logo: https://mma.prnewswire.com/media/2015772/5054067/Aidoc_Always_On_AI_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/aidoc-pioneers-next-generation-ai-with-care1-foundation-model-revolutionizing-ct-imaging-standards-302319664.html

SOURCE Aidoc

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

22 minutes ago

April 23, 2026

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

22 minutes ago

April 23, 2026

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2. Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3. Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4. Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.

Technology

Noritz upgrades EZ Pro Series of tankless water heaters with larger, multi-function panel display for faster installation and servicing

Published

22 minutes ago

April 23, 2026

Improved, fully integrated diagnostic interface eliminates the need for a separate remote controller, providing key system status data and enhanced digital controls to ease startup, operation, and maintenance for pro installers and service techs.

FOUNTAIN VALLEY, Calif., April 23, 2026 /PRNewswire/ — Noritz America, an international leader in tankless and electric heat pump water heaters and high-efficiency combination boilers, has further enhanced its EZ Series Pro line of residential condensing tankless water heaters by expanding both the size and the functionality of the units’ built-in control panel, whose user-friendly digital interface is mounted prominently on the front exterior.

Providing upgraded monitoring and diagnostic capabilities, the multi-function panel display allows professional installers to view system status, temperature settings, service reminders, maintenance data, error codes, error history, and (if applicable) recirculation timing settings. All of this vital information is built in and readily accessible on the water heater. Besides eliminating the need for a separate, external remote controller, the panel enables guided setup during installation and faster, more effective troubleshooting.

In addition, installers and users can monitor and program the unit remotely via Bluetooth® connectivity that works alongside the panel, using the EZ Start Plus app on their smartphones. A separate external remote is optional.

“The intent of our upgrade efforts was to create a more satisfying user experience for both the professional and the consumer,” says Noritz Executive Vice President and General Manager Jason Fleming. “We focused on simplified installation, advanced diagnostics, and giving professionals and their customers easier, more responsive control of the water heater.”

Essential Features of the Multi-Function Panel

Below are the main features and capabilities of the upgraded, built-in, multi-function panel and related control system:

Digital temperature control: Professional installers and service technicians will find it easier to use the enlarged panel to set the output water temperature to 100° – 140° Fahrenheit. Temperature settings are available in increments as small as 5°F.

Key benefits: More precise temperature control for professionals and, as a result, safer, more consistent hot-water delivery for end users.

Integrated Bluetooth connectivity; no more dip switches: The EZ Start Plus app enables installers and service techs to perform system setup, adjust the temperature, run diagnostics and share this information electronically with Noritz Technical Support. Installers can even register the water heater to qualify for the accompanying warranty.

Key benefits: Simplified startups mean faster installs, minimizing the manual programming that installers previously had to perform. Smartphone-based control and troubleshooting eliminate the need for old-style manual adjustment of physical dip switches.

Improved service access: Even the physical design of the EZ Series Pro has been reengineered to work more effectively with the newly enhanced multi-function panel.

Key benefits: The latched, snap-lock front cover enables quicker access to components for easier maintenance and servicing.

Industry-Best Warranty

The upgraded EZ Series Pro continues to include three models, all with a Uniform Energy Factor of 0.98, the highest efficiency rating in the tankless water heater industry:

EZ71: input range — 12,800 to 160,000 BTU/hour; flow rate — 0.4 to 9.0 gallons per minute; turndown ratio — 12.5:1EZ98: 12,800 to 180,000 BTUh; 0.4 to 9.8 gpm; 14:1;EZ111: 12,800 to 199,900 BTUh; 0.4 to 11.1 gpm; 16:1.

All three units carry a 25-year limited warranty on their stainless steel heat exchangers, the longest such protection in the industry. Further protection includes a five-year limited parts warranty and one year for reasonable labor.

The water heaters use natural gas but are field-convertible to LP with a parts kit included with every unit. Two water heaters can be linked using Noritz’s optional Quick Connect linkage to double the hot-water flow rate.

Designed for wall-mounting indoors, the EZ Series Pro heaters can be direct-vented with two-, three-, or four-inch Schedule 40 or Schedule 80 PVC or CPVC, or two-inch or three-inch polypropylene venting. They can also be installed outdoors in milder year-round climates using an optional vent cap.

All EZ Series Pro models have received approvals from CSA, NSF5, NSF372, and are Low NOx approved by the South Coast Air Quality Management District (Rule 1146.2).

For more information on the newly upgraded Noritz EZ Series Pro, visit: https://ezseries.noritz.com/

A short product video is available at: https://youtu.be/m5iDn7sOGMc

For more information on the full line of Noritz tankless water heating products, visit www.noritz.com. You can also contact us by telephone at 866.766.7489 or by email at support@noritz.com.

For editorial assistance, contact John O’Reilly or Emma Wurzer at GreenHouse Digital PR, 15255 South 94th Avenue, Suite 500 | Orland Park, IL 60462; tel.: 708.428.6385; e-mail: john@greenhousedigitalpr.com | emma@greenhousedigitalpr.com.

Hi-res versions of photographs to accompany this press release are available for immediate download by using this link: https://noritz.greenhousedigitalpr.com/ez-series-pro-upgrades.

NORITZ AMERICA CORPORATION, a subsidiary of Noritz Japan, has corporate offices in Fountain Valley, Calif., and Atlanta, offering a full line of tankless water heaters and high-efficiency combination boilers to meet the hot water demands of residential and commercial applications. Noritz supports its products with a national network of skilled representatives and employees committed to providing our communities with the finest products and services by helping consumers live a more comfortable, efficient, and healthy lifestyle. For more information on Noritz America and the entire line of Noritz’s ENERGY STAR® tankless water heaters, please call (877) 986-6748 or visit our website at www.noritz.com.

CONTACT:
Andrew Tran
Noritz America
(714) 433-7813
atran@noritz.com

View original content:https://www.prnewswire.com/news-releases/noritz-upgrades-ez-pro-series-of-tankless-water-heaters-with-larger-multi-function-panel-display-for-faster-installation-and-servicing-302752319.html

SOURCE Noritz